- Home
- WYY vs IPSC Comparison
WYY vs IPSC Comparison
Compare WYY & IPSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WYY
- IPSC
- Stock Information
- Founded
- WYY 1991
- IPSC 2019
- Country
- WYY United States
- IPSC United States
- Employees
- WYY N/A
- IPSC N/A
- Industry
- WYY EDP Services
- IPSC Medicinal Chemicals and Botanical Products
- Sector
- WYY Technology
- IPSC Health Care
- Exchange
- WYY Nasdaq
- IPSC Nasdaq
- Market Cap
- WYY 48.9M
- IPSC 49.1M
- IPO Year
- WYY 1998
- IPSC 2021
- Fundamental
- Price
- WYY $7.17
- IPSC $0.56
- Analyst Decision
- WYY Strong Buy
- IPSC Strong Buy
- Analyst Count
- WYY 3
- IPSC 5
- Target Price
- WYY $8.67
- IPSC $3.33
- AVG Volume (30 Days)
- WYY 74.0K
- IPSC 1.4M
- Earning Date
- WYY 11-13-2025
- IPSC 11-07-2025
- Dividend Yield
- WYY N/A
- IPSC N/A
- EPS Growth
- WYY N/A
- IPSC N/A
- EPS
- WYY N/A
- IPSC N/A
- Revenue
- WYY $144,421,640.00
- IPSC $114,128,000.00
- Revenue This Year
- WYY $9.19
- IPSC $1,589.94
- Revenue Next Year
- WYY $13.16
- IPSC N/A
- P/E Ratio
- WYY N/A
- IPSC N/A
- Revenue Growth
- WYY 16.25
- IPSC 5491.77
- 52 Week Low
- WYY $2.19
- IPSC $0.34
- 52 Week High
- WYY $7.55
- IPSC $1.83
- Technical
- Relative Strength Index (RSI)
- WYY 67.81
- IPSC 48.92
- Support Level
- WYY $6.33
- IPSC $0.55
- Resistance Level
- WYY $7.55
- IPSC $0.65
- Average True Range (ATR)
- WYY 0.52
- IPSC 0.04
- MACD
- WYY 0.04
- IPSC -0.00
- Stochastic Oscillator
- WYY 83.48
- IPSC 18.00
About WYY WidePoint Corporation
WidePoint Corp is a provider of Technology Management as a Service (TMaaS) that consists of federally certified communications management, identity management, interactive bill presentment and analytics, and an Information Technology as a Service solution. Its solutions include Telecom Lifecycle Management, Digital billing communications solutions, and Mobile and Identity management. Geographically, the company generates a majority of its revenue from the United States and the rest from Europe.
About IPSC Century Therapeutics Inc.
Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks.